Brain Protection in Schizophrenia, Mood and Cognitive Disorders /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Dordrecht :
Springer Netherlands : Imprint: Springer,
2010.
|
| Edición: | 1st ed. 2010. |
| Materias: |
Tabla de Contenidos:
- Neuroprotective Strategies and Mechanisms
- Brain Protection in Neuropsychiatric Disorders: Past, Present and Future Challenges
- Towards a New Paradigm in Neuroprotection and Neuroplasticity
- What Protects Patients with Schizophrenia from Developing Alzheimer Pathology?
- Assessing In Vivo Neurodegeneration in Schizophrenia Using Magnetic Resonance
- Vulnerability of the Brain to Neuropsychiatric Disorders Resulting from Abnormal Thyroid Hormone or Vitamin D Homeostasis
- Phosphatidylinositol 3-Kinase/Glycogen Synthase Kinase and Mitogen-Activated Protein Kinase Signalling Cascades in Neuronal Cell Survival: What the Neurotrophins Have Taught Us and Implications For Neuropsychiatric Disorders
- One-Compound-Multi-Targets at Amyloid ? Cascade Offered By Bis(7)-Cognitin, a Novel Anti-Alzheimer’s Dimer
- Common Pathways to Neurodegeneration and Co-morbid Depression
- Breakdown of the Blood-Brain Barrier in Stress Alters Cognitive Dysfunction and Induces Brain Pathology: New Perspectives for Neuroprotective Strategies
- Oxidative Stress and Neurodegeneration: An Inevitable Consequence of Aging? Implications for Therapy
- Carbon Nanotubes as Electrical Interfaces with Neurons
- II. Neuroprotective Treatment and Neuromodulation
- Is a Neuroprotective Therapy Suitable for Schizophrenia Patients?
- Recombinant Human Erythropoietin: Novel Approach to Neuroprotection and Neuroregeneration in Schizophrenia
- Neuroprotective Agents in Mood Disorders: Pathophysiological and Therapeutic Implications
- Neuroprotection in Bipolar Depression
- New Antiepileptic Drugs in Neuropsychiatric Disorders – Basic Mechanisms Related to Clinical Efficacy
- The Neuroprotective Efficacy of Vitamins
- Smoking and Mental Disorders: Focus on Neuroprotection
- Inhibition of Glycine Transporter-1 Improves the Functional Outcome of Schizophrenia
- The Role of Oxytocin in Neuropsychiatric Disorders: Concepts and Mechanisms
- Neuromodulation for Neuropsychiatric Disorders: Novel Techniques -Vagus Nerve Stimulation, Transcranial Magnetic Stimulation, Transcranial Direct Current Stimulation, and Deep Brain Stimulation.